Iranian researchers in Amirkabir University of Technology have succeeded in creating antibacterial wound dressings by green chemistry means. It is also possible to monitor the wound healing process due to the product’s transparency.
Safacto is the first Recombinant Clotting Factor VIII produced in Iran for hemophilia patients and is a biosimilar of the drug Xyntha, produced by Pfizaer.
In a multinational study led by Iranian researchers, it has been proved that long term heroin-use considerably influences the quality of the semen, leading to infertility.
In a study led by two Iranian researchers at UCLA, an injectable scaffold has been developed that improves axon regeneration in mice with spinal cord injuries.
The Spanish media, while widely covering the testing of the Iranian second Covid-19 vaccine called "Kopars", acknowledged that Iran has emerged as one of the global Covid-19 vaccine manufacturers.
60% of Iran's total exported knowledge-based products are linked with biotechnology.